Dai et al proved by immunohistochemistry, western blotting and quantitative PCR that the reduced level of exosomal CLEC3B in hepatocellular carcinoma promoted metastasis and angiogenesis through AMPK and VEGF signals, which was likely to be a potential therapeutic target for HCC 29. This evidence concerns the gene VEGFA and hepatocellular carcinoma.